SuperworthWaters EPS WAT
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jul 4, 2026
- $4.01
- Latest quarter, Q2 FY26
- −$1.39
- −156% on a year earlier
- Fiscal year 2025
- $10.77
- +1% on the year before
Waters' earnings per share was $4.01 over the twelve months to Jul 4, 2026, down 64% on a year earlier.
In its latest quarter, Q2 FY26, it was −$1.39, down 156% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 5% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $10.77 | +1% |
| FY2024 | $10.71 | −1% |
| FY2023 | $10.85 | −8% |
| FY2022 | $11.75 | +5% |
| FY2021 | $11.18 | +34% |
| FY2020 | $8.36 | −5% |
| FY2019 | $8.78 | +14% |
| FY2018 | $7.67 | +3937% |
| FY2017 | $0.19 | −97% |
| FY2016 | $6.40 | +13% |
| FY2015 | $5.66 | +11% |
| FY2014 | $5.09 | −2% |
| FY2013 | $5.21 | +0% |
| FY2012 | $5.19 | +11% |
| FY2011 | $4.69 | +15% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$1.39 | −156% | $4.01 | |
| Q1 FY26 | −$0.87 | −143% | $7.87 | |
| Q4 FY25 | $3.77 | −3% | $10.77 | |
| Q3 FY25 | $2.50 | −8% | $10.88 | |
| Q2 FY25 | $2.47 | +3% | $11.09 | |
| Q1 FY25 | $2.03 | +18% | $11.02 | |
| Q4 FY24 | $3.88 | +6% | $10.71 | |
| Q3 FY24 | $2.71 | +19% | $10.48 | |
| Q2 FY24 | $2.40 | −6% | $10.04 | |
| Q1 FY24 | $1.72 | −28% | $10.19 | |
| Q4 FY23 | $3.65 | −4% | $10.85 | |
| Q3 FY23 | $2.27 | −13% | $11.01 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Waters' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| WATWaters | $4.01 | −64% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| IQVIQVIA | $8.06 | +17% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| ILMNIllumina | $5.38 | −32% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| DHRDanaher | $5.63 | +20% a year |
| Peer median | $8.73 |
Where Waters ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Waters
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.